Chemical Structure (Raloxifene HCl Tablets Usp 1)
Raloxifene Hydrochloride Tablet, Film Coated
Product Images NDC 65162-057
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 65162-057). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 1 (Raloxifene HCl Tablets Usp 2)
The text provides data on total hip mean percentage change from baseline among subjects in placebo and Raloxifene HCl 24-month studies, as well as data from a study on hysterectomized women taking Raloxifene HCl and conjugated estrogens. The percentage change is tracked over a period of 24 months, with data collected at various timepoints. The analysis is performed according to the intent to treat method, with the last observation carried forward.*
1 (Raloxifene HCl Tablets Usp 3)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
